Vimarsana
Biggest News Aggregation in the World

Page 24 - Cm Management News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cm Management. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cm Management Today - Breaking & Trending Today

National Bank Financial Brokers Reduce Earnings Estimates for Centerra Gold Inc. (NYSE:CGAU) - Vimarsana News

National Bank Financial Brokers Reduce Earnings Estimates for Centerra Gold Inc. (NYSE:CGAU)

Centerra Gold Inc. (NYSE:CGAU – Free Report) – Research analysts at National Bank Financial dropped their FY2023 earnings per share estimates for Centerra Gold in a report issued on Tuesday, August 1st. National Bank Financial analyst M. Parkin now anticipates that the company will post earnings per share of $0.00 for the year, down from […]

Coherus BioSciences (NASDAQ:CHRS) Given New $20.00 Price Target at HC Wainwright - Vimarsana News

Coherus BioSciences (NASDAQ:CHRS) Given New $20.00 Price Target at HC Wainwright

Coherus BioSciences (NASDAQ:CHRS – Free Report) had its price target trimmed by HC Wainwright from $24.00 to $20.00 in a research report sent to investors on Thursday, MarketBeat reports. The firm currently has a buy rating on the biotechnology company’s stock. A number of other equities analysts also recently issued reports on the company. Barclays […]

Evolus (NASDAQ:EOLS) PT Raised to $27.00 - Vimarsana News

Evolus (NASDAQ:EOLS) PT Raised to $27.00

Evolus (NASDAQ:EOLS – Get Free Report) had its target price upped by stock analysts at HC Wainwright from $16.00 to $27.00 in a research note issued on Thursday, Marketbeat Ratings reports. The brokerage presently has a “buy” rating on the stock. HC Wainwright’s target price suggests a potential upside of 173.28% from the stock’s current […]

StockNews.com Lowers DURECT (NASDAQ:DRRX) to Sell - Vimarsana News

StockNews.com Lowers DURECT (NASDAQ:DRRX) to Sell

StockNews.com cut shares of DURECT (NASDAQ:DRRX – Free Report) from a hold rating to a sell rating in a research report report published on Wednesday morning. Separately, HC Wainwright reiterated a buy rating and issued a $32.00 price objective on shares of DURECT in a report on Tuesday, April 11th. DURECT Price Performance Shares of […]

Rigel Pharmaceuticals (NASDAQ:RIGL) Rating Increased to Buy at StockNews.com - Vimarsana News

Rigel Pharmaceuticals (NASDAQ:RIGL) Rating Increased to Buy at StockNews.com

Rigel Pharmaceuticals (NASDAQ:RIGL – Get Free Report) was upgraded by equities research analysts at StockNews.com from a “hold” rating to a “buy” rating in a note issued to investors on Thursday. Separately, HC Wainwright reaffirmed a “buy” rating and issued a $15.00 price target on shares of Rigel Pharmaceuticals in a report on Wednesday. One […]